Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/rockefeller-university-press/type-i-interferon-friend-or-foe-My3MUFx8GZ
References (121)
-
A. Cooper, J. Pearl, J. Brooks, S. Ehlers, I. Orme (2000)
Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium tuberculosis in the Murine LungInfection and Immunity, 68
-
T. Fehr, G. Schoedon, B. Odermatt, Thomas Holtschke, M. Schneemann, M. Bachmann, T. Mak, I. Horak, R. Zinkernagel (1997)
Crucial Role of Interferon Consensus Sequence Binding Protein, but neither of Interferon Regulatory Factor 1 nor of Nitric Oxide Synthesis for Protection Against Murine ListeriosisThe Journal of Experimental Medicine, 185
-
Y. Nagano, Y. Kojima (1958)
[Inhibition of vaccinia infection by a liquid factor in tissues infected by homologous virus].Comptes rendus des seances de la Societe de biologie et de ses filiales, 152 11
-
A. Pandey, Yibin Yang, Zhaozhao Jiang, S. Fortune, F. Coulombe, M. Behr, K. Fitzgerald, C. Sassetti, M. Kelliher (2009)
NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosisPLoS Pathogens, 5
-
H. Young, J. Bream (2007)
IFN-γ: Recent Advances in Understanding Regulation of Expression, Biological Functions, and Clinical ApplicationsCurrent Topics in Microbiology and Immunology, 316
-
Javier Carrero, B. Calderon, E. Unanue (2004)
Type I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria InfectionThe Journal of Experimental Medicine, 200
-
G. Gautier, M. Humbert, Florence Deauvieau, Mathieu Scuiller, J. Hiscott, E. Bates, G. Trinchieri, C. Caux, P. Garrone (2005)
A type I interferon autocrine–paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cellsThe Journal of Experimental Medicine, 201
-
(1958)
Inhibition de l’infection vaccinale par un facteur liquide dans le tissu infecte par le virus homologue -
Ralph Benedict1, Julie Bobholz2 (2007)
Multiple SclerosisSemin Neurol, 27
-
T. Decker, Mathias Müller, Silvia Stockinger (2005)
The Yin and Yang of type I interferon activity in bacterial infectionNature Reviews Immunology, 5
-
V. Pascual, D. Chaussabel, J. Banchereau (2010)
A genomic approach to human autoimmune diseases.Annual review of immunology, 28
-
(1919)
La grippe à Paris en 1919 -
J. Wenzel, T. Tüting (2008)
An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis".The Journal of investigative dermatology, 128 10
-
M. Colonna, G. Trinchieri, Yong‐jun Liu (2004)
Plasmacytoid dendritic cells in immunityNature Immunology, 5
-
Xiaoxia Li, S. Leung, Sajjad Qureshi, J. Darnell, G. Stark (1996)
Formation of STAT1-STAT2 Heterodimers and Their Role in the Activation of IRF-1 Gene Transcription by Interferon- (*)The Journal of Biological Chemistry, 271
-
C. Asselin‐Paturel, A. Boonstra, M. Dalod, I. Durand, Nadia Yessaad, C. Dezutter‐Dambuyant, A. Vicari, A. O’Garra, C. Biron, F. Brière, G. Trinchieri (2001)
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphologyNature Immunology, 2
-
L. Rönnblom, G. Alm (2003)
Systemic lupus erythematosus and the type I interferon systemArthritis Research & Therapy, 5
-
T. Kawai, S. Akira (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 11
-
L. Huys, F. Hauwermeiren, L. Dejager, E. Dejonckheere, S. Lienenklaus, S. Weiss, G. Leclercq, C. Libert (2009)
Type I interferon drives tumor necrosis factor–induced lethal shockThe Journal of Experimental Medicine, 206
-
William O'Connor, M. Kamanaka, C. Booth, T. Town, S. Nakae, Y. Iwakura, J. Kolls, R. Flavell (2009)
A protective function for interleukin 17A in T cell–mediated intestinal inflammationNature Immunology, 10
-
A. Yarilina, Kyung-Hyun Park-Min, T. Antoniv, Xiaoyu Hu, L. Ivashkiv (2008)
TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon–response genesNature Immunology, 9
-
Noseworthy (2000)
Multiple sclerosisN. Engl. J. Med., 343
-
Interferon- (cid:1) promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis -
S. Moschos, J. Kirkwood (2007)
Present role and future potential of type I interferons in adjuvant therapy of high-risk operable melanoma.Cytokine & growth factor reviews, 18 5-6
-
R. Besch, Hendrik Poeck, Tobias Hohenauer, D. Senft, G. Häcker, C. Berking, V. Hornung, S. Endres, T. Ruzicka, S. Rothenfusser, G. Hartmann (2009)
Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.The Journal of clinical investigation, 119 8
-
Y. Chiu, J. MacMillan, Zhijian Chen (2009)
RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I PathwayCell, 138
-
T. Ishihara, M. Aga, K. Hino, Chie Ushio, Mutsuko Taniguchi, K. Iwaki, M. Ikeda, M. Kurimoto (2005)
Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha.Biomedical research, 26 4
-
T. Taniguchi, A. Takaoka (2001)
A weak signal for strong responses: interferon-alpha/beta revisitedNature Reviews Molecular Cell Biology, 2
-
R. Yoshida, H. Murray, C. Nathan (1988)
Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or betaThe Journal of Experimental Medicine, 167
-
S. Stanley, J. Johndrow, P. Manzanillo, J. Cox (2007)
The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis1The Journal of Immunology, 178
-
G. Mancuso, A. Midiri, C. Biondo, C. Beninati, S. Zummo, R. Galbo, F. Tomasello, M. Gambuzza, Giancarlo Macrì, Alessia Ruggeri, T. Leanderson, G. Teti (2007)
Type I IFN Signaling Is Crucial for Host Resistance against Different Species of Pathogenic Bacteria1The Journal of Immunology, 178
-
Xiaoxia Li, S. Leung, Ian Kerr, George Stark (1997)
Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signalingMolecular and Cellular Biology, 17
-
A. Triantafyllopoulou, Claus-Werner Franzke, S. Seshan, G. Perino, G. Kalliolias, M. Ramanujam, N. Rooijen, A. Davidson, L. Ivashkiv (2010)
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesProceedings of the National Academy of Sciences, 107
-
A. Boasso, Andrew Hardy, S. Anderson, M. Dolan, G. Shearer (2008)
HIV-Induced Type I Interferon and Tryptophan Catabolism Drive T Cell Dysfunction Despite Phenotypic ActivationPLoS ONE, 3
-
L. Morel (2010)
Genetics of SLE: evidence from mouse modelsNature Reviews Rheumatology, 6
-
G. Oganesyan, Supriya Saha, Beichu Guo, Jeannie He, A. Shahangian, B. Zarnegar, Andrea Perry, G. Cheng (2006)
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral responseNature, 439
-
C. Münz, J. Lünemann, M. Getts, S. Miller (2009)
Antiviral immune responses: triggers of or triggered by autoimmunity?Nature Reviews Immunology, 9
-
Marina Karaghiosoff, R. Steinborn, P. Kovarik, G. Kriegshäuser, M. Baccarini, Birgit Donabauer, U. Reichart, T. Kolbe, C. Bogdan, T. Leanderson, D. Levy, T. Decker, Mathias Müller (2003)
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shockNature Immunology, 4
-
M. Ferrantini, I. Capone, F. Belardelli (2007)
Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.Biochimie, 89 6-7
-
P. Rizza, F. Moretti, F. Belardelli (2010)
Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunityAutoimmunity, 43
-
Jongdae Lee, D. Rachmilewitz, E. Raz (2006)
Homeostatic Effects of TLR9 Signaling in Experimental ColitisAnnals of the New York Academy of Sciences, 1072
-
U. Hasan, C. Caux, I. Perrot, A. Doffin, C. Ménétrier-Caux, G. Trinchieri, M. Tommasino, J. Vlach (2007)
Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNsProceedings of the National Academy of Sciences, 104
-
G. Uzé, D. Monneron (2007)
IL-28 and IL-29: newcomers to the interferon family.Biochimie, 89 6-7
-
A. Boxel-Dezaire, M. Rani, George Stark (2006)
Complex modulation of cell type-specific signaling in response to type I interferons.Immunity, 25 3
-
A. Bowie, Leonie Unterholzner (2008)
Viral evasion and subversion of pattern-recognition receptor signallingNature Reviews. Immunology, 8
-
Byrnes (2001)
Type I interferons and IL-12: convergence and cross-regulation among mediators of cellular immunityEur. J. Immunol., 31
-
Benjamin Reutterer, Silvia Stockinger, Andreas Pilz, D. Soulat, Renate Kastner, Sandra Westermayer, T. Rülicke, Mathias Müller, T. Decker (2008)
Type I IFN are host modulators of strain‐specific Listeria monocytogenes virulenceCellular Microbiology, 10
-
F. Mattei, G. Schiavoni, D. Tough (2010)
Regulation of immune cell homeostasis by type I interferons.Cytokine & growth factor reviews, 21 4
-
R. Goldszmid, U. Hasan, G. Trinchieri (2009)
Double stranded RNA tricks melanoma cells into committing suicidePigment Cell & Melanoma Research, 22
-
Ting Jia, Ingrid Leiner, G. Dorothée, K. Brandl, E. Pamer (2009)
MyD88 and Type I Interferon Receptor-Mediated Chemokine Induction and Monocyte Recruitment during Listeria monocytogenes Infection1The Journal of Immunology, 183
-
C. Guiducci, Mei Gong, Zhaohui Xu, M. Gill, D. Chaussabel, T. Meeker, Jean Chan, Tracey Wright, M. Punaro, S. Bolland, V. Soumelis, J. Banchereau, R. Coffman, V. Pascual, F. Barrat (2010)
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupusNature, 465
-
M. Berry, C. Graham, Finlay Mcnab, Zhaohui Xu, S. Bloch, T. Oni, K. Wilkinson, R. Banchereau, Jason Skinner, R. Wilkinson, Charlie Quinn, D. Blankenship, R. Dhawan, J. Cush, A. Mejias, O. Ramilo, O. Kon, V. Pascual, J. Banchereau, D. Chaussabel, A. O’Garra (2010)
An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human TuberculosisNature, 466
-
J. Swann, Y. Hayakawa, N. Zerafa, K. Sheehan, B. Scott, R. Schreiber, P. Hertzog, M. Smyth (2007)
Type I IFN Contributes to NK Cell Homeostasis, Activation, and Antitumor Function1The Journal of Immunology, 178
-
G. Jego, A. Palucka, J. Blanck, Cecile Chalouni, V. Pascual, J. Banchereau (2003)
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.Immunity, 19 2
-
S. McWhirter, Roman Barbalat, K. Monroe, Mary Fontana, M. Hyodo, N. Joncker, K. Ishii, S. Akira, M. Colonna, Zhijian Chen, K. Fitzgerald, Y. Hayakawa, R. Vance (2009)
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMPThe Journal of Experimental Medicine, 206
-
D. Ganguly, G. Chamilos, R. Lande, Josh Gregorio, S. Meller, V. Facchinetti, B. Homey, F. Barrat, T. Zal, M. Gilliet (2009)
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8The Journal of Experimental Medicine, 206
-
(1978)
Anti-viral activity induced by culturing lymphocytes with tumor-derived or virustransformed cells -
Ryan O’Connell, Supriya Saha, Sagar Vaidya, K. Bruhn, G. Miranda, B. Zarnegar, Andrea Perry, Bidong Nguyen, T. Lane, T. Taniguchi, Jeff Miller, G. Cheng (2004)
Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes InfectionThe Journal of Experimental Medicine, 200
-
V. Brinkmann, T. Geiger, S. Alkan, C. Heusser (1993)
Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cellsThe Journal of Experimental Medicine, 178
-
T. Henry, G. Kirimanjeswara, T. Ruby, Jonathan Jones, Kaitian Peng, M. Perret, Lena Ho, J. Sauer, Y. Iwakura, D. Metzger, D. Monack (2010)
Type I IFN Signaling Constrains IL-17A/F Secretion by γδ T Cells during Bacterial InfectionsThe Journal of Immunology, 184
-
C. Plumlee, Carolyn Lee, A. Beg, T. Decker, H. Shuman, C. Schindler (2009)
Interferons Direct an Effective Innate Response to Legionella pneumophila Infection*The Journal of Biological Chemistry, 284
-
Silvia Stockinger, T. Decker (2008)
Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes.Immunobiology, 213 9-10
-
M. Prchal, Andreas Pilz, O. Simma, K. Lingnau, A. Gabain, B. Strobl, Mathias Müller, T. Decker (2009)
Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity.Vaccine, 27 Suppl 6
-
Javier Carrero, B. Calderon, E. Unanue (2006)
Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenesThe Journal of Experimental Medicine, 203
-
I. Marié, J. Durbin, D. Levy (1998)
Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7The EMBO Journal, 17
-
H. Qiu, Yijun Fan, A. Joyee, Shuhe Wang, Xiaobin Han, Hong Bai, L. Jiao, N. Rooijen, Xi Yang (2008)
Type I IFNs Enhance Susceptibility to Chlamydia muridarum Lung Infection by Enhancing Apoptosis of Local Macrophages1The Journal of Immunology, 181
-
Jenn Miller, Ying Ma, Jiantao Bian, K. Sheehan, J. Zachary, J. Weis, R. Schreiber, J. Weis (2008)
A Critical Role for Type I IFN in Arthritis Development following Borrelia burgdorferi Infection of Mice1The Journal of Immunology, 181
-
Prafullakumar Tailor, T. Tamura, H. Kong, T. Kubota, Mayumi Kubota, P. Borghi, L. Gabriele, K. Ozato (2007)
The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8.Immunity, 27 2
-
D. Gough, N. Messina, L. Hii, J. Gould, K. Sabapathy, Ashley Robertson, J. Trapani, D. Levy, P. Hertzog, C. Clarke, R. Johnstone (2010)
Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1PLoS Biology, 8
-
C. Buss, B. Opitz, A. Hocke, J. Lippmann, V. Laak, S. Hippenstiel, M. Krüll, N. Suttorp, J. Eitel (2010)
Essential Role of Mitochondrial Antiviral Signaling, IFN Regulatory Factor (IRF)3, and IRF7 in Chlamydophila pneumoniae-Mediated IFN-β Response and Control of Bacterial Replication in Human Endothelial CellsThe Journal of Immunology, 184
-
J. Bekisz, S. Baron, C. Balinsky, A. Morrow, K. Zoon (2010)
Antiproliferative Properties of Type I and Type II InterferonPharmaceuticals, 3
-
H. Häcker, V. Redecke, B. Blagoev, I. Kratchmarova, L. Hsu, Gang Wang, M. Kamps, E. Raz, H. Wagner, G. Häcker, M. Mann, M. Karin (2006)
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6Nature, 439
-
G. Trinchieri, D. Santoli (1978)
Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysisThe Journal of Experimental Medicine, 147
-
L. Rönnblom, G. Alm, M. Eloranta (2009)
Type I interferon and lupusCurrent Opinion in Rheumatology, 21
-
C. Manca, L. Tsenova, S. Freeman, A. Barczak, M. Tovey, P. Murray, C. Barry, G. Kaplan (2005)
Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 25 11
-
K. Lin, Yasushi Suzuki, H. Nakano, E. Ramsburg, M. Gunn (2008)
CCR2+ Monocyte-Derived Dendritic Cells and Exudate Macrophages Produce Influenza-Induced Pulmonary Immune Pathology and Mortality1The Journal of Immunology, 180
-
K. Kelly-Scumpia, P. Scumpia, M. Delano, J. Weinstein, A. Cuenca, J. Wynn, L. Moldawer (2010)
Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10The Journal of Experimental Medicine, 207
-
Lynda Bennett, A. Palucka, E. Arce, E. Arce, Victoria Cantrell, Victoria Cantrell, J. Borvák, J. Banchereau, V. Pascual, V. Pascual (2003)
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodThe Journal of Experimental Medicine, 197
-
P. Ling, M. Warren, S. Vogel (1985)
Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages.Journal of immunology, 135 3
-
A. Shahangian, E. Chow, X. Tian, Jason Kang, A. Ghaffari, Su-yang Liu, J. Belperio, G. Cheng, Jane Deng (2009)
Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice.The Journal of clinical investigation, 119 7
-
M. Prinz, Hauke Schmidt, A. Mildner, K. Knobeloch, U. Hanisch, Jennifer Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, R. Lang, Roland Martin, R. Gold, B. Becher, W. Brück, U. Kalinke (2008)
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.Immunity, 28 5
-
M. Levings, R. Sangregorio, F. Galbiati, S. Squadrone, R. Malefyt, M. Roncarolo (2001)
IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1The Journal of Immunology, 166
-
B. Salaun, P. Romero, S. Lebecque (2007)
Toll‐like receptors’ two‐edged sword: when immunity meets apoptosisEuropean Journal of Immunology, 37
-
H. Weighardt, Simone Kaiser-Moore, Sylvia Schlautkötter, T. Rossmann-Bloeck, U. Schleicher, C. Bogdan, B. Holzmann (2006)
Type I IFN Modulates Host Defense and Late Hyperinflammation in Septic Peritonitis1The Journal of Immunology, 177
-
C. Guiducci, R. Coffman, F. Barrat (2009)
Signalling pathways leading to IFN‐α production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indicationsJournal of Internal Medicine, 265
-
M. Levings, R. Sangregorio, F. Galbiati, S. Squadrone, R. Malefyt, M. Roncarolo (2001)
IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.Journal of immunology, 166 9
-
L. Antonelli, A. Rothfuchs, R. Gonçalves, E. Roffê, A. Cheever, A. Báfica, A. Salazar, C. Feng, A. Sher (2010)
Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.The Journal of clinical investigation, 120 5
-
Manira Rayamajhi, J. Humann, Kristi Penheiter, K. Andreasen, L. Lenz (2010)
Induction of IFN-αβ enables Listeria monocytogenes to suppress macrophage activation by IFN-γThe Journal of Experimental Medicine, 207
-
Beichu Guo, E. Chang, G. Cheng (2008)
The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.The Journal of clinical investigation, 118 5
-
U. Malik, D. Makower, S. Wadler (2001)
Interferon‐mediated fatigueCancer, 92
-
D. Haskard (2007)
Faculty Opinions recommendation of Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. -
N. Rose (2010)
Autoimmunity, infection and adjuvantsLupus, 19
-
J. Gold, Y. Hoshino, S. Hoshino, Marcus Jones, A. Nolan, M. Weiden (2004)
Exogenous Gamma and Alpha/Beta Interferon Rescues Human Macrophages from Cell Death Induced by Bacillus anthracisInfection and Immunity, 72
-
P. Puccetti (2007)
On watching the watchers: IDO and type I/II IFNEuropean Journal of Immunology, 37
-
Victoria Auerbuch, D. Brockstedt, Nicole Meyer-Morse, M. O’Riordan, D. Portnoy (2004)
Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenesThe Journal of Experimental Medicine, 200
-
M. Freudenberg, T. Merlin, C. Kalis, Y. Chvatchko, H. Stübig, C. Galanos (2002)
Cutting Edge: A Murine, IL-12-Independent Pathway of IFN-γ Induction by Gram-Negative Bacteria Based on STAT4 Activation by Type I IFN and IL-18 Signaling1The Journal of Immunology, 169
-
A. Navarini, M. Recher, K. Lang, P. Georgiev, S. Meury, A. Bergthaler, L. Flatz, J. Billé, R. Landmann, B. Odermatt, H. Hengartner, R. Zinkernagel (2006)
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responsesProceedings of the National Academy of Sciences, 103
-
Tomohiro Watanabe, N. Asano, S. Fichtner-Feigl, P. Gorelick, Y. Tsuji, Y. Matsumoto, T. Chiba, I. Fuss, A. Kitani, W. Strober (2010)
NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway.The Journal of clinical investigation, 120 5
-
A. Isaacs, J. Lindenmann (1957)
Virus interference. I. The interferonProceedings of the Royal Society of London. Series B - Biological Sciences, 147
-
K. Nguyen, L. Cousens, L. Doughty, G. Pien, J. Durbin, C. Biron (2000)
Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradoxNature Immunology, 1
-
Hemant Agrawal, N. Jacob, E. Carreras, Sandra Bajaña, C. Putterman, Sean Turner, B. Neas, A. Mathian, M. Koss, W. Stohl, S. Kovats, C. Jacob (2009)
Deficiency of Type I IFN Receptor in Lupus-Prone New Zealand Mixed 2328 Mice Decreases Dendritic Cell Numbers and Activation and Protects from Disease1The Journal of Immunology, 183
-
G. Mancuso, M. Gambuzza, A. Midiri, C. Biondo, S. Papasergi, S. Akira, G. Teti, C. Beninati (2009)
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cellsNature Immunology, 10
-
Diego Jaitin, G. Schreiber (2007)
Upregulation of a small subset of genes drives type I interferon-induced antiviral memory.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 27 8
-
H. Murray, C. Nathan
AGONIST AND ANTAGONIST EFFECTS OF INTERFERON a AND # ON ACTIVATION OF HUMAN MACROPHAGES Two Classes of Interferon y Receptors and Blockade of the High-Affinity Sites by Interferon a or -
N. Dikopoulos, A. Bertoletti, A. Kröger, H. Hauser, R. Schirmbeck, J. Reimann (2005)
Type I IFN Negatively Regulates CD8+ T Cell Responses through IL-10-Producing CD4+ T Regulatory 1 Cells1The Journal of Immunology, 174
-
M. Biggioggero, Lisa Gabbriellini, P. Meroni (2010)
Type I interferon therapy and its role in autoimmunityAutoimmunity, 43
-
T. Fernandes‐Alnemri, Je-Wook Yu, Christine Juliana, L. Solórzano, Seokwon Kang, Jianghong Wu, P. Datta, M. McCormick, Lan Huang, Erin McDermott, L. Eisenlohr, C. Landel, E. Alnemri (2010)
The AIM2 inflammasome is critical for innate immunity against Francisella tularensisNature immunology, 11
-
G. Comi (2009)
Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.Clinical therapeutics, 31 6
-
C. Manca, L. Tsenova, A. Bergtold, S. Freeman, Micah Tovey, J. Musser, C. Barry, V. Freedman, G. Kaplan (2001)
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/βProceedings of the National Academy of Sciences of the United States of America, 98
-
D. Choubey, X. Duan, E. Dickerson, Larissa Ponomareva, R. Panchanathan, Hui Shen, R. Srivastava (2010)
Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 30 6
-
M. Shmulevitz, L. Pan, Katy Garant, D. Pan, Patrick Lee (2010)
Oncogenic Ras promotes reovirus spread by suppressing IFN-beta production through negative regulation of RIG-I signaling.Cancer research, 70 12
-
H. Young, J. Bream (2007)
IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications.Current topics in microbiology and immunology, 316
-
L. Maza, E. Peterson, J. Goebel, C. Fennie, C. Czarniecki (1985)
Interferon-induced inhibition of Chlamydia trachomatis: dissociation from antiviral and antiproliferative effectsInfection and Immunity, 47
-
G. Trinchieri, D. Santoli, R. Dee, B. Knowles (1978)
Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulationThe Journal of Experimental Medicine, 147
-
O. Haller, G. Kochs, F. Weber (2005)
The interferon response circuit: Induction and suppression by pathogenic virusesVirology, 344
-
A. Takaoka, Y. Mitani, H. Suemori, Mitsuharu Sato, T. Yokochi, S. Noguchi, N. Tanaka, T. Taniguchi (2000)
Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains.Science, 288 5475
-
A. Yarilina, E. Dicarlo, L. Ivashkiv (2007)
Suppression of the Effector Phase of Inflammatory Arthritis by Double-Stranded RNA Is Mediated by Type I IFNs1The Journal of Immunology, 178
-
Y. Zhai, Bo Qiao, F. Gao, Xiu‐da Shen, A. Vardanian, R. Busuttil, J. Kupiec-Weglinski (2007)
Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusionHepatology, 47
-
M. Ferrantini, I. Capone, F. Belardelli (2007)
Interferon-α and cancer : Mechanisms of action and new perspectives of clinical useBiochimie, 89
-
A. Byrnes, Xiaojing Ma, P. Cuomo, Kiwon Park, L. Wahl, S. Wolf, Huanfang Zhou, G. Trinchieri, C. Karp (2001)
Type I interferons and IL‐12: convergence and cross‐regulation among mediators of cellular immunityEuropean Journal of Immunology, 31
-
G. Dunn, A. Bruce, K. Sheehan, V. Shankaran, R. Uppaluri, J. Bui, Mark Diamond, Catherine Koebel, C. Arthur, J. White, R. Schreiber (2005)
A critical function for type I interferons in cancer immunoeditingNature Immunology, 6
- Publisher
- Rockefeller University Press
- Copyright
- Copyright © 2010 by the Rockefeller University Press
- ISSN
- 0022-1007
- eISSN
- 1540-9538
- DOI
- 10.1084/jem.20101664
- pmid
- 20837696
- Publisher site
- See Article on Publisher Site
Abstract
Although the role of type I interferon (IFN) in the protection against viral infections has been known and studied for decades, its role in other immunologically relevant scenarios, including bacterial infections, shock, autoimmunity, and cancer, is less well defined and potentially much more complicated. Submitted: 11 August 2010 Accepted: 30 August 2010 This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms ). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ ).
Journal
The Journal of Experimental Medicine – Rockefeller University Press
Published: Sep 27, 2010